Novel cannabinoid receptors

AJ Brown - British journal of pharmacology, 2007 - Wiley Online Library
Cannabinoids have numerous physiological effects. In the years since the molecular
identification of the G protein‐coupled receptors CB1 and CB2, the ion channel TRPV1, and …

Sphingosine-1-phosphate and its receptors: structure, signaling, and influence

H Rosen, RC Stevens, M Hanson… - Annual review of …, 2013 - annualreviews.org
The sphingosine-1-phosphate (S1P) receptor signaling system has biological and medical
importance and is the first lipid G protein–coupled receptor (GPCR) structure to be solved to …

Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate

S Liu, N Paknejad, L Zhu, Y Kihara, M Ray… - Nature …, 2022 - nature.com
Lysophospholipids are bioactive lipids and can signal through G-protein-coupled receptors
(GPCRs). The best studied lysophospholipids are lysophosphatidic acid (LPA) and …

Evolutionary origins of the endocannabinoid system

JM McPartland, I Matias, V Di Marzo, M Glass - Gene, 2006 - Elsevier
Endocannabinoid system evolution was estimated by searching for functional orthologs in
the genomes of twelve phylogenetically diverse organisms: Homo sapiens, Mus musculus …

Aiming drug discovery at lysophosphatidic acid targets

G Tigyi - British journal of pharmacology, 2010 - Wiley Online Library
Lysophosphatidic acid (LPA, 1‐radyl‐2‐hydroxy‐sn‐glycero‐3‐phosphate) is the prototype
member of a family of lipid mediators and second messengers. LPA and its naturally …

Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo

H Zhang, X Xu, J Gajewiak, R Tsukahara… - Cancer …, 2009 - aacrjournals.org
Signal transduction modifiers that modulate the lysophosphatidic acid (LPA) pathway have
potential as anticancer agents. Herein, we describe metabolically stabilized LPA analogues …

[HTML][HTML] Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain

ME Lin, RR Rivera, J Chun - Journal of Biological Chemistry, 2012 - Elsevier
Lysophosphatidic acid (LPA) is a bioactive lipid that serves as an extracellular signaling
molecule acting through cognate G protein-coupled receptors designated LPA 1–6 that …

[HTML][HTML] Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation

JR Williams, AL Khandoga, P Goyal, JI Fells… - Journal of Biological …, 2009 - Elsevier
Lysophosphatidic acid (LPA) is a ligand for LPA 1–3 of the endothelial differentiation gene
family G-protein-coupled receptors, and LPA 4–8 is related to the purinergic family G-protein …

Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer

MA Dacheux, DD Norman, GJ Tigyi, SC Lee - Pharmacology & therapeutics, 2023 - Elsevier
Lysophosphatidic acid (LPA) is a bioactive lipid mediator that regulates a variety of cellular
functions such as cell proliferation, migration, survival, calcium mobilization, cytoskeletal …

Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis

DL Baker, Y Fujiwara, KR Pigg, R Tsukahara… - Journal of Biological …, 2006 - jbc.org
Autotaxin (ATX, nucleotide pyrophosphate/phosphodiesterase-2) is an autocrine motility
factor initially characterized from A2058 melanoma cell-conditioned medium. ATX is known …